EUS-FNA for Patients With Antithrombotic Agents

Completed

• Conditions: Solid Tumor

• Registration Number: NCT01798654
• Lead Sponsor: Hokkaido Pancreatobiliary Endoscopic Intervention Study Group

Brief Summary

The purpose of this study to evaluate a safety of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for patients with antithrombotic agents.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-09
• Study First Submitted: 2013-02-22
• Study First Submitted QC: 2013-02-25
• Study First Posted: 2013-02-26
• Primary Completion: 2015-09
• Status Verified: 2016-02
• Last Update Submitted: 2016-02-18
• Last Update Posted: 2016-02-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 84

Inclusion Criteria

• Undergo EUS-FNA
• take antithrombotic agents

Exclusion Criteria

• Cystic lesion

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patients who suffered bleeding complication	One week

Trial Locations

Locations (1)

Hokkaido University Graduate School of Medicine; 🇯🇵 Sapporo, Japan